Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease.

Lin JP, Vitek L, Schwertner HA.

Clin Chem. 2010 Oct;56(10):1535-43. doi: 10.1373/clinchem.2010.151043. Epub 2010 Aug 6. Review.

2.

Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin.

Schwertner HA, Vítek L.

Atherosclerosis. 2008 May;198(1):1-11. doi: 10.1016/j.atherosclerosis.2008.01.001. Epub 2008 Mar 17. Review.

PMID:
18343383
3.

The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.

Haffner SM.

Am J Cardiol. 2006 Jan 16;97(2A):3A-11A. Epub 2005 Dec 5. Review.

PMID:
16442931
4.

Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons?

Franchini M, Targher G, Lippi G.

Adv Clin Chem. 2010;50:47-63. Review.

PMID:
20521440
5.

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

Unwin N, Shaw J, Zimmet P, Alberti KG.

Diabet Med. 2002 Sep;19(9):708-23. Review.

PMID:
12207806
6.

Sialic acid: a novel marker of cardiovascular disease?

Gopaul KP, Crook MA.

Clin Biochem. 2006 Jul;39(7):667-81. Epub 2006 Apr 19. Review.

PMID:
16624269
7.

Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.

Reaven GM.

Panminerva Med. 2005 Dec;47(4):201-10. Review.

PMID:
16489319
8.

Gene-environment interaction in hypertension, stroke and atherosclerosis in experimental models and supportive findings from a world-wide cross-sectional epidemiological survey: a WHO-cardiac study.

Yamori Y, Nara Y, Mizushima S, Murakami S, Ikeda K, Sawamura M, Nabika T, Horie R.

Clin Exp Pharmacol Physiol Suppl. 1992;20:43-52. Review.

PMID:
1446409
9.

The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.

Kendall DM, Harmel AP.

Am J Manag Care. 2002 Dec;8(20 Suppl):S635-53; quiz S654-7. Review.

10.

Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases.

Wagner KH, Wallner M, Mölzer C, Gazzin S, Bulmer AC, Tiribelli C, Vitek L.

Clin Sci (Lond). 2015 Jul;129(1):1-25. doi: 10.1042/CS20140566. Review.

PMID:
25881719
11.

Genetic markers of inflammation and their role in cardiovascular disease.

Raman K, Chong M, Akhtar-Danesh GG, D'Mello M, Hasso R, Ross S, Xu F, Paré G.

Can J Cardiol. 2013 Jan;29(1):67-74. doi: 10.1016/j.cjca.2012.06.025. Epub 2012 Sep 19. Review.

PMID:
22999193
12.

Association of plasma parathyroid hormone with metabolic syndrome and risk for cardiovascular disease.

Huang C, Shapses SA, Wang X.

Endocr Pract. 2013 Jul-Aug;19(4):712-7. doi: 10.4158/EP12440.RA. Review.

PMID:
23512391
13.

Effects of serum bilirubin on atherosclerotic processes.

Kang SJ, Lee C, Kruzliak P.

Ann Med. 2014 May;46(3):138-47. doi: 10.3109/07853890.2014.895588. Epub 2014 Apr 10. Review.

PMID:
24720602
14.

Is bilirubin a marker of vascular disease and/or cancer and is it a potential therapeutic target?

Breimer LH, Mikhailidis DP.

Curr Pharm Des. 2011 Nov;17(33):3644-55. Review.

PMID:
22074434
15.

Obesity.

Musaad S, Haynes E.

IARC Sci Publ. 2011;(163):441-52. Review.

PMID:
22997876
16.

Does bilirubin protect against developing diabetes mellitus?

Breimer LH, Mikhailidis DP.

J Diabetes Complications. 2016 May-Jun;30(4):728-37. doi: 10.1016/j.jdiacomp.2016.01.019. Epub 2016 Jan 26. Review.

PMID:
26922581

Supplemental Content

Support Center